MaxCyte regains Nasdaq minimum bid price compliance; matter now closed
MaxCyte received a Nasdaq letter on June 10, 2026 stating that its common stock closed at $1.00 or above for the last 10 consecutive business days, from May 27 to June 9, 2026. Nasdaq closed the matter, and the company says it has regained compliance with the minimum bid price rule. This removes the bid price deficiency that Nasdaq had flagged in March 2026.
- Nasdaq notice on March 16, 2026 cited a closing bid price below $1.00 for 30 consecutive trading days
- Nasdaq letter dated June 10, 2026 confirmed the closing bid price was at $1.00 or greater from May 27 to June 9, 2026
- Nasdaq closed the matter under Listing Rule 5450(a)(1)